H-1B sponsorship profile: Zydus Pharmaceuticals USA, Inc. Across U.S. Department of Labor LCA disclosures, Zydus Pharmaceuticals USA, Inc filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (10 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Zydus Pharmaceuticals USA, Inc’s H-1B petitions range from $70,100 at the low end to $207,675 at the high end, with a petition-weighted average of $123,048. That range reflects the mix of occupations the company sponsors, led by Supply Chain Analyst (1 petitions at $70,100 avg), followed by Senior Manager, Regulatory Affairs & Supply Chain and Senior Manager, Regulatory Affairs. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Zydus Pharmaceuticals USA, Inc is headquartered in PENNINGTON, NJ under NAICS code 325412, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Zydus Pharmaceuticals USA, Inc ranks. By H-1B petition volume, Zydus Pharmaceuticals USA, Inc is #16,610 of 119,880 employers nationally and #1,387 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.